BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6385952)

  • 1. Cell mediated immunity to islet cells: lessons from animal studies.
    Kolb H; Kiesel U; Flohr K; Greulich B; Freytag G; Kolb-Bachofen V
    Behring Inst Mitt; 1984 Jul; (75):33-8. PubMed ID: 6385952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction.
    Bedossa P; Bendelac A; Bach JF; Carnaud C
    Eur J Immunol; 1989 Oct; 19(10):1947-51. PubMed ID: 2684673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse.
    Campbell IL; Oxbrow L; Koulmanda M; Harrison LC
    J Immunol; 1988 Feb; 140(4):1111-6. PubMed ID: 2963859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus.
    Scherbaum WA; Seissler J
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():88-94. PubMed ID: 8839261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targeting of islet autoantigens.
    Stadinski B; Kappler J; Eisenbarth GS
    Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of type 1 diabetes.
    Campbell IL; Harrison LC
    Mol Biol Med; 1990 Aug; 7(4):299-309. PubMed ID: 2233244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].
    Hengartner H
    Verh Dtsch Ges Pathol; 1994; 78():177-9. PubMed ID: 7533982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
    Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
    Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
    J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
    Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 1 diabetes mellitus, autoimmune disease: physiopathologic aspects and practical applications].
    Timsit J; Boitard C; Bach JF
    Ann Biol Clin (Paris); 1991; 49(3):149-53. PubMed ID: 2064084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.